Patent details
EP3458053
Title:
USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS
Basic Information
- Publication number:
- EP3458053
- PCT Application Number:
- US2017033688
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP178003109
- PCT Publication Number:
- WO2017201501
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS
- French Title of Invention:
- UTILISATION DU RILUZOLE, DE PROMÉDICAMENTS DU RILUZOLE OU D'ANALOGUES DU RILUZOLE AVEC DES IMMUNOTHÉRAPIES POUR TRAITER LES CANCERS
- German Title of Invention:
- VERWENDUNG VON RILUZOL, RILUZOLPRODRUGS ODER RILUZOLANALOGA MIT IMMUNTHERAPIEN ZUR BEHANDLUNG VON KREBS
- SPC Number:
-
Dates
- Filing date:
- 19/05/2017
- Grant date:
- 08/12/2021
- EP Publication Date:
- 27/03/2019
- PCT Publication Date:
- 23/11/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/12/2021
- EP B1 Publication Date:
- 08/12/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/05/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/01/2022
-
-
- Name:
- Biohaven Therapeutics Ltd.
- Address:
- 215 Church Street, New Haven, CT 06510, United States (US)
History of Owners
- From:
- 01/12/2021
- To:
- 21/01/2022
- Name:
- Biohaven Pharmaceutical Holding Company Ltd.
- Address:
- 234 Church Street
Suite 301, New Haven, CT 06520, United States (US)
Agent
1
- Name:
- MARKS & CLERK LLP
- From:
- 12/08/2022
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
2
- Name:
- MARKS & CLERK LLP
- From:
- 04/02/2022
- Address:
- B.P. 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
- 12/08/2022
Inventor
- Name:
- CORIC, Vladimir
- Address:
- United States (US)
Priority
- Priority Number:
- 201662339433 P
- Priority Date:
- 20/05/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/428;
C07D 277/82;
A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202149
- Publication date:
- 08/12/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202150
- Publication date:
- 15/12/2021
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202208
- Publication date:
- 23/02/2022
- Description:
- Transfer of Rights
Annual Fees
- Annual Fee Due Date:
- 02/06/2025
- Annual Fee Number:
- 9
- Annual Fee Amount:
- 115 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 13/05/2024
- Last Annual Fee Paid Number:
- 8
- Last Annual Fee Paid Amount:
- 99 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM